Mapping of Lymph Node Metastasis and Survival For pN+ Superficial Esophageal Squamous Cell Carcinoma

Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05526456

Enrollment

207

Registered

2022-09-02

Start date

2012-02-01

Completion date

2022-05-15

Last updated

2022-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

National Cancer Center/Cancer Hospital

Brief summary

With the deeper tumor invasion, the higher LNM rate beside the bilateral recurrent laryngeal nerves(RLN) was.

Interventions

PROCEDUREEsophagectomy

McKeown, Ivor-Lewis, and Sweet procedure

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

44 Years to 73 Years

Inclusion criteria

* Our predefined search strategy identified pT1N+ ESCC cases without preoperative treatment, between February 2012 and April 2022.

Exclusion criteria

* The patients were excluded because they were (1)less than 10 lymph nodes removed; (2) lacked specific sites of LNM; or (3) incomplete follow-up information.

Design outcomes

Primary

Measure	Time frame
LNM rates of the 207 thoracic T1N+ ESCC patients.	2012.2-2022.4

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026